Richard Williams
Chief Tech/Sci/R&D Officer bei KINNATE BIOPHARMA INC.
Vermögen: 138 222 $ am 31.03.2024
Profil
Richard Williams is currently the Chief Medical Officer at Kinnate Biopharma, Inc. He previously worked as a Clinical Research Medical Director at Amgen, Inc. from 2010 to 2012, as a Senior Medical Director at Puma Biotechnology, Inc. from 2012 to 2015, as the Head-Early Development Oncology Group at Amgen, Inc. from 2016 to 2017, as the Group Director-Medical at GRAIL LLC in 2017, and as the Chief Medical Officer & Head-Oncology Programs at Wuxi NextCode Genomics USA, Inc. from 2018 to 2020.
Dr. Williams holds a doctorate degree from The University of Queensland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
KINNATE BIOPHARMA, INC.
0,11% | 13.03.2024 | 51 963 ( 0,11% ) | 138 222 $ | 31.03.2024 |
Aktive Positionen von Richard Williams
| Unternehmen | Position | Beginn |
|---|---|---|
| KINNATE BIOPHARMA INC. | Chief Tech/Sci/R&D Officer | 01.06.2020 |
Ehemalige bekannte Positionen von Richard Williams
| Unternehmen | Position | Ende |
|---|---|---|
Wuxi NextCode Genomics USA, Inc.
 Wuxi NextCode Genomics USA, Inc. Data Processing ServicesTechnology Services Wuxi NextCode Genomics USA, Inc. provides genomic data. It's solutions include custom patient cohorts, sequencing, analysis, AI services, sequence miner, and clinical sequence analyzer. The company was founded by Jeffrey Gulcher and Hannes Smarason and is headquartered in Cambridge, MA. | Chief Tech/Sci/R&D Officer | 01.06.2020 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Chief Tech/Sci/R&D Officer | 01.02.2018 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2017 |
| PUMA BIOTECHNOLOGY, INC. | Chief Tech/Sci/R&D Officer | 01.09.2015 |
| AMGEN INC. | Corporate Officer/Principal | 01.11.2012 |
Ausbildung von Richard Williams
| The University of Queensland | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| PUMA BIOTECHNOLOGY, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Technology |
Wuxi NextCode Genomics USA, Inc.
Wuxi NextCode Genomics USA, Inc. Data Processing ServicesTechnology Services Wuxi NextCode Genomics USA, Inc. provides genomic data. It's solutions include custom patient cohorts, sequencing, analysis, AI services, sequence miner, and clinical sequence analyzer. The company was founded by Jeffrey Gulcher and Hannes Smarason and is headquartered in Cambridge, MA. | Technology Services |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Kinnate Biopharma, Inc. operates as a biopharmaceutical company engaged in the research and development of Kinnate Discovery Engine that targets genomic drivers of cancer. The company was founded by Stephen W. Kaldor and Eric A. Murphy in January 2018 and is headquartered in San Diego, CA. | Health Technology |
